Ignite Creation Date:
2024-05-05 @ 11:40 AM
Last Modification Date:
2024-10-26 @ 9:11 AM
Study NCT ID:
NCT00101595
Status:
COMPLETED
Last Update Posted:
2011-04-14
First Post:
2005-01-12
Brief Title:
Dasatinib BMS-354825 in Subjects With Lymphoid Blast Phase Chronic Myeloid Leukemia or Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia
Sponsor:
Bristol-Myers Squibb
Organization:
Bristol-Myers Squibb